Ann Kurian | Biomaterials | Best Researcher Award

Posted on by sciencefather

Ms. Ann Kurian | Biomaterials | Best Researcher Award

Ann Anu Kurian is a biomedical researcher with over seven years of experience specializing in cellular biology and RNA-based gene delivery. She holds an MS in Biomedical Science from Morehouse School of Medicine and a BTech in Biotechnology from Lovely Professional University. Currently an Associate Researcher II and Lab Manager at the Icahn School of Medicine at Mount Sinai, her work focuses on cardiac and skeletal muscle regeneration using modified mRNA technologies. She has contributed to multiple peer-reviewed publications and has been recognized with several academic honors, including a Presidential Scholarship and research presentation awards.

Ms.Ann Kurian , Icahn school of medicine, United States.

Profile

GOOGLESCHOLAR

SCOPUS

🎓 Education

Ann Anu Kurian holds a Master of Science in Biomedical Science from Morehouse School of Medicine in Atlanta, Georgia, completed between August 2015 and May 2017. She also earned a Bachelor of Technology in Biotechnology from Lovely Professional University in India, where she studied from August 2009 to May 2013.

🌟 Experience

With over seven years of research experience, Ann currently serves as an Associate Researcher II and Research Lab Manager at the Icahn School of Medicine at Mount Sinai in New York. Since November 2023, she has been working in the Gregorio Laboratory, conducting research focused on understanding the components and molecular mechanisms that regulate actin architecture in cardiac and skeletal muscle during both normal development and disease. Prior to this, she held a similar role in the Zangi Laboratory from August 2017 to November 2023, where she led projects utilizing modified mRNA to improve cardiac outcomes post-injury and managed various aspects of laboratory operations. Her professional journey began in India at VWR International from January 2014 to August 2015, where she supported chemical projects, maintained product data in SAP, and enhanced product descriptions.

🏅 Awards and Honors

Ann has been recognized for her academic and research achievements, receiving a Presidential Scholarship from Morehouse School of Medicine in 2017. The same year, she earned a travel award to attend the Georgia Academy of Science annual meeting. She also presented her research at several prestigious conferences, including the Ninth AACR Conference on The Science of Cancer Health Disparities, the Curtis L. Parker Student Research Symposium, and the Georgia Academy of Science annual meeting.

📖Skill

Ann is skilled in a wide range of technical and laboratory techniques. Her expertise includes molecular biology methods such as PCR, gel electrophoresis, cloning, RNA and DNA extraction, modified mRNA production, and LNP characterization. She is proficient in cell culture techniques, cardiomyocyte isolation, tissue sectioning, histological staining, and confocal microscopy. Her experience also includes data analysis, IVIS imaging, and statistical evaluation. She has strong capabilities in animal handling and laboratory management, including procurement, equipment maintenance, and regulatory compliance.

🔬 Research Focus

Ann’s research centers on cellular biology and RNA-based gene delivery systems, particularly in the context of cardiac and skeletal muscle biology. Her work has explored the use of modified mRNA technologies to induce gene expression for therapeutic regeneration following cardiac injury. Her contributions to the field are reflected in numerous peer-reviewed publications, addressing areas such as cardiomyocyte proliferation, ischemic injury, cardiac regeneration, and mRNA optimization.

📘 Publications

Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration
Authors: A Magadum, N Singh, AA Kurian, I Munir, T Mehmood, K Brown, …
Year: 2020
Journal: Circulation (Volume 141, Issue 15, Pages 1249–1265)

Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction
Authors: Y Hadas, AS Vincek, E Youssef, MM Żak, E Chepurko, N Sultana, …
Year: 2020
Journal: Circulation (Volume 141, Issue 11, Pages 916–930)

Ablation of a single N-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration
Authors: A Magadum, N Singh, AA Kurian, MTK Sharkar, E Chepurko, L Zangi
Year: 2018
Journal: Molecular Therapy – Nucleic Acids (Volume 13, Pages 133–143)

Optimization of 5′ untranslated region of modified mRNA for use in cardiac or hepatic ischemic injury
Authors: N Sultana, Y Hadas, MTK Sharkar, K Kaur, A Magadum, AA Kurian, …
Year: 2020
Journal: Molecular Therapy Methods & Clinical Development (Volume 17, Pages 622–633)

Direct reprogramming induces vascular regeneration post muscle ischemic injury
Authors: K Kaur, Y Hadas, AA Kurian, MM Żak, J Yoo, A Mahmood, H Girard, …
Year: (Year not provided)
Journal: Molecular Therapy (Volume 29, Issue 10, Pages 3042–3058)

Dr Markus Laubach | Biomaterials | Best Researcher Award

Posted on by sciencefather

Dr Markus Laubach | Biomaterials | Best Researcher Award

Dr Markus Laubach, LMU University Hospital Munich, Germany

Dr. Markus Laubach 🎓🩺 is a distinguished researcher in orthopaedics and medical innovation. Holding a Ph.D. in preclinical assessment of novel medical devices, an MBA in Healthcare Management, and certifications in emergency medicine, he combines clinical expertise with research excellence. 🏥🔬 His groundbreaking work focuses on scaffold-guided bone regeneration, 3D-printed implants, and bone grafting techniques, published in top journals like Biomaterials Science and Scientific Reports. 💡📚 Dr. Laubach has secured over EUR 350,000 in grants and won prestigious awards, including the Best Poster Award at DKOU 2023. 🌍 He actively collaborates globally, advancing orthopaedic trauma care. 🦴✨

Publication Profile

Orcid

Scopus

Education and Training🎓

Dr. Markus Laubach 🎓 began his educational journey at Stefan-George-Gymnasium, earning his Abitur in 2007 🎒. He trained as a paramedic 🚑 at Arbeiter-Samariter-Bund in 2008. He pursued Medicine 🩺 at Maastricht University (2010–2016) and earned his Dr. med. from Charité Berlin in 2019 📚, focusing on brain aging and executive functioning 🧠. Further, he specialized in Emergency Medicine 🚨 and completed his Ph.D. at QUT 🦴 (2020–2023), researching bone graft aspirator devices. Recently, he earned an MBA 🎓 in Health Care Management 🏥. Currently, he advances orthopaedic research at LMU Munich through the prestigious Feodor Lynen Fellowship 🌍.

Professional Experience💼

Dr. Markus Laubach 🩺 has extensive professional experience in orthopaedics and trauma surgery. He is currently a Resident at the LMU University Hospital 🏥, Musculoskeletal University Center Munich (2023–present). Previously, he worked as a Resident at RWTH Aachen University Hospital (2016–2020) 🦴, advancing his surgical expertise. Dr. Laubach further honed his skills in medtech commercialization through The BridgeTech Program 🌐 in Australia (2021–2022). His medical journey began as a Paramedic 🚑 with organizations like Malteser Hilfsdienst (2011–2016), Arbeiter Samariter Bund (2009–2010), and DRK Rettungsdienst GmbH (2008–2009), reflecting his dedication to emergency medical care and patient well-being 🤝.

Research Focus Area 🌱🧬

Markus Laubach is a researcher specializing in biomaterials, bone regeneration, and spinal surgery innovations. His work primarily focuses on advancing implants, scaffolds, and bone grafts for clinical applications, particularly in lumbar spinal fusion and bone defect treatments. He is involved in designing 3D printable, patient-specific bioresorbable bone scaffolds to promote bone regeneration. Laubach’s research extends to the development of novel bone graft harvesting techniques and the assessment of biodegradable interbody cages. His work intersects with orthopaedic trauma, regenerative medicine, and biomechanics. 🦴🧬🩺

Memberships

Dr. Markus Laubach is an active member of several prestigious medical and research organizations. He is affiliated with AO Trauma 🦵, focusing on advancing trauma care, and the Deutsche Gesellschaft für Orthopädie und Unfallchirurgie (DGOU) 🇩🇪, which promotes orthopedic and trauma surgery excellence. He also participates in the Gesellschaft für Extremitätenverlängerung und -rekonstruktion (GEVR) 🦴, dedicated to extremity reconstruction. Additionally, Dr. Laubach is a member of the Orthopaedic Research Society (ORS) 🔬 and the Tissue Engineering and Regenerative Medicine International Society (TERMIS) 🌍, contributing to cutting-edge research in tissue engineering and regenerative medicine.

Awards🏆

Dr. Markus Laubach has received notable recognition for his scientific contributions. In 2023, he was awarded the Best Poster Award at the DKOU 2023 in Berlin 🏆. His research has attracted competitive grants, including EUR 182,022.36 from the Bundesministerium für Bildung und Forschung for a clinical study on tibial transverse callus distraction in diabetic foot ulcer patients 💉, and EUR 39,600 from the Feodor Lynen Return Fellowship 🏅. Dr. Laubach also secured funding from the Volkswagen Foundation (EUR 38,000) and Clive & Vera Ramaciotti Foundation (AUD 130,000) for innovative bone defect treatments using 3D-printed scaffolds.

Publication Top Notes📄✨

Advances in implants and bone graft types for lumbar spinal fusion surgery

Modular design workflow for 3D printable bioresorbable patient-specific bone scaffolds: extended features and clinical validation.

Preclinical assessment of a novel aspirator device for intramedullary bone graft harvesting

Lost in translation: the lack of agreement between surgeons and scientists regarding biomaterials research and innovation for treating bone defects

An innovative intramedullary bone graft harvesting concept as a fundamental component of scaffold-guided bone regeneration: A preclinical in vivo validation

Chirurg*innen vs. Wissenschaftler*innen – Mind the Gap! DKOU Science-Slam 2023: Umfragestudie zu Biomaterialien bei Knochendefekten [Surgeons vs. scientists—Mind the gap!: Survey study on biomaterials for bone defects]

How framing bias impacts preferences for innovation in bone tissue engineering

Semi-automated scaffold design workflow to facilitate clinical translation of scaffold guided bone regeneration

The development of a modular design workflow for 3D printable bioresorbable patient-specific bone scaffolds to facilitate clinical translation

Histological and Immunohistochemical Characterization of Osteoimmunological Processes in Scaffold-Guided Bone Regeneration in an Ovine Large Segmental Defect Model

Conclusion

Dr. Markus Laubach’s robust academic foundation, exceptional research achievements, successful funding track record, and dedication to clinical translation make him an excellent candidate for the Best Researcher Award. His work directly addresses critical gaps in bone defect treatments, contributing both to scientific innovation and practical healthcare advancements.

Sailee Chowdhury | Biomaterials | Best Researcher Award

Posted on by sciencefather

Sailee Chowdhury | Biomaterials | Best Researcher Award

Prof Sailee Chowdhury, BCDA College of Pharmacy & Technology, India

Prof. Sailee Chowdhury is a distinguished academic and researcher in pharmaceutical technology with 17+ years of teaching experience 📚✨. She holds a Ph.D. in Pharmaceutical Technology and has over 11 years of postdoctoral research experience. Her work spans flavonoids, nanoparticles, tissue engineering, and sustainable practices in drug discovery 🌿🔬. Prof. Chowdhury has published extensively in reputed journals and authored several book chapters, showcasing her commitment to knowledge dissemination 📖. As Head of the Department, she leads with excellence in education and administration 🏫🎓. Her active role in conferences and institutional committees reflects her influence and dedication to research ethics and innovation 🌍💡.

Publication Profile

Scopus

Orcid

Educational Background 🎓

Prof. Sailee Chowdhury is a highly qualified academic with a Ph.D. in Pharmaceutical Technology from MAKAUT, Kolkata, awarded in 2013 🎓🔬. She holds an M.Pharm in Pharmaceutical Chemistry with First Class honors (SGPA 9) from Biju Pattnaik University of Technology (2006) 🧪📘 and qualified GATE in 2004 🎯. Her academic journey began with a B.Pharm degree (Honors) scoring 80.3% from Burdwan University in 2004, followed by stellar performances in Higher Secondary (68%, WBCHSE, 2000) and Madhyamik (87%, WBBSE, 1998) 📚🌟. Prof. Chowdhury’s consistent academic excellence forms the foundation of her illustrious career in pharmaceutical education and research 🌍📖.

Professional Experience and Contributions 💼

Prof. Sailee Chowdhury brings over 17 years of teaching experience at BCDA College of Pharmacy & Technology, Kolkata 🎓📘, where she has progressed through roles from Lecturer to Professor and currently serves as Head of the Department of Pharmaceutical Chemistry (since April 2022) 🧪🔬. Post-Ph.D., she has over 11 years of academic and research experience 🌟. She actively contributes to UG and PG education, administrative roles, NBA accreditation, and institutional committees 📊📜. A recognized academic leader, she has organized national and international seminars, served as a reviewer for reputed journals and books, and contributed extensively to pharmaceutical education 🌍💡.

Participation in Conference Seminar & Workshops 🌐

Prof. Sailee Chowdhury has actively participated in numerous national and international conferences, seminars, and workshops, serving in roles such as Joint Convenor, Evaluator, Co-chairperson, Chairperson, Panelist, and Advisory Member 🎤📚. Highlights include the 72nd Indian Pharmaceutical Congress in Nagpur, the International Conference on Drug Discovery at Brainware University 🌍💊, and multiple events organized by institutions like Jadavpur University and Amity University 🧪📖. She has chaired scientific sessions on medicinal plants and sustainable pharmaceutical practices, fostering academia-industry partnerships, and evaluating cutting-edge research, reflecting her commitment to advancing pharmaceutical education and research 🌱🔬.

Research Focus Area 🌱🧬

Prof. Sailee Chowdhury’s research spans pharmaceutical sciences, biomaterials, and sustainable innovation 🌿🔬. Her work includes the role of flavonoids and phenolics in gut microbiota modulation and combating metabolic diseases and biotic stress 🩺🍃. She advances enzymology in drug discovery 💊🧪, sustainable practices in the pharmaceutical industry 🌍⚗️, and plant-protein-based future foods 🌱🍽️. Her expertise extends to cutting-edge biomaterials, exploring nanoparticles for gene expression and osteoconductivity 🦴🧬, alginate biocomposites for drug delivery 🦠, and silk fibroin scaffolds for tissue engineering 🧵🏗️. This multidisciplinary focus aims to enhance healthcare, sustainability, and innovation, positioning her as a leader in pharmaceutical research. 🌟📘

Publication Top Notes📄✨

Flavonoids and their metabolites: Impact on gut microbiota in connection with chronic metabolic diseases

Phenolics as Shielding Counterparts from Plants to Combat Biotic Stress Mediated by Microbes and Nematodes

Enzymology in drug discovery

Sustainable Practices in the Pharmaceutical Industry: Development and Adoption

Applications of Modified Plant Protein-Based Future Foods

Nanoparticles for triggering gene expression and osteoconductivity

Biocomposites of Alginates in Drug Delivery

Silk Fibroin–Based Biomaterial Scaffold in Tissue Engineering: Present Persuasive Perspective

Conclusion

Prof. Sailee Chowdhury demonstrates a holistic profile of academic excellence, significant research contributions, and impactful teaching and leadership roles. These attributes strongly position her as a suitable nominee for the Best Researcher Award. Her focus on innovative and sustainable pharmaceutical practices adds further value to her candidacy.